Ondansetron Augmentation in Treatment-resistant OCD
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether ondansetron augmentation to SSRI will improve
and ondansetron discontinuation will result in worsening of obsessive compulsive symptoms
among obsessive compulsive disorder resistant patients.